Cargando…
Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections
Moxifloxacin hydrochloride ophthalmic solution 0.5% (Vigamox(®)) is the ocular formulation/adaptation of moxifloxacin. Moxifloxacin is a broad spectrum 8-methoxyfluoroquinolone which terminates bacterial growth by binding to DNA gyrase (topoisomerase II) and topoisomerase IV, essential bacterial enz...
Autor principal: | Miller, Darlene |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698721/ https://www.ncbi.nlm.nih.gov/pubmed/19668391 |
Ejemplares similares
-
Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride
por: Mandal, Sonjoy, et al.
Publicado: (2012) -
Development and characterisation of thermo reversible mucoadhesive moxifloxacin hydrochloride in situ ophthalmic gel
por: Dholakia, M., et al.
Publicado: (2012) -
Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis
por: Williams, Patricia B, et al.
Publicado: (2010) -
A validated HPTLC method for estimation of moxifloxacin hydrochloride in tablets
por: Dhillon, Vandana, et al.
Publicado: (2010) -
Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
por: Cervantes, Lorenzo J, et al.
Publicado: (2011)